Tourmaline Bio Inc

TRML

Equity

ISIN null / Valor 130396424

NASDAQ (2025-10-29)

USD 47.98%

Tourmaline Bio Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Tourmaline Bio Inc is a biotechnology firm focused on the development and commercialization of innovative therapies in the healthcare sector. Founded by Sandeep, who brings nearly two decades of experience in healthcare, biotech investment, and company development, Tourmaline aims to leverage its leadership's extensive background to advance its portfolio. Sandeep's prior roles include significant positions at KVP Capital, Immunovant, Roivant Sciences, and QVT Financial, highlighting a career deeply embedded in biotech company growth and public transactions. Alongside Sandeep, Gerhard, with over twenty years of experience in the biopharma industry, contributes his expertise in drug development, commercial strategy, and business development, having previously led significant initiatives and product launches at Gilead Sciences and Pfizer. Tourmaline Bio Inc's leadership is characterized by a rich history of strategic and operational success across various stages of drug development and commercialization, positioning the company to make impactful advances in the healthcare and biotech industries.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

77.0%1Y

202%3Y

%5Y

Performance

79.2%1Y

96.6%3Y

103%5Y

Volatility